In a patient whose serum sodium rose from 131 mmol/L to 134 mmol/L after reducing lisinopril (angiotensin‑converting‑enzyme inhibitor) from 40 mg to 20 mg, with normal urine sodium, normal urine osmolality, and low serum osmolality, should sodium tablets be added?

Do Not Add Sodium Tablets

In this patient whose sodium improved from 131 to 134 mmol/L after reducing lisinopril, with normal urine sodium, normal urine osmolality, and low serum osmolality, you should NOT add sodium tablets. The clinical picture indicates the hyponatremia was lisinopril-induced and is already resolving with dose reduction alone.

Clinical Reasoning

The Hyponatremia is Resolving

Your patient's sodium rose 3 mmol/L (from 131 to 134 mmol/L) simply by halving the lisinopril dose. This demonstrates:

• The ACE inhibitor was the culprit
• The intervention is working
• The trajectory is toward normalization

Laboratory Pattern Confirms Drug-Induced Mechanism

The combination of:

• Low serum osmolality (dilutional hyponatremia)
• Normal urine sodium (kidneys appropriately excreting sodium)
• Normal urine osmolality (no inappropriate concentration)

This pattern is consistent with ACE inhibitor-induced hyponatremia through increased antidiuretic hormone effect and polydipsia 1, 2. The normal urine studies exclude SIADH (which would show inappropriately concentrated urine) and cerebral salt wasting (which would show high urine sodium losses).

ACE Inhibitors and Hyponatremia

Lisinopril can cause hyponatremia through a specific mechanism: while it blocks peripheral conversion of angiotensin I to angiotensin II, circulating angiotensin I enters the brain where it converts to angiotensin II, stimulating both thirst and ADH release 1. Cases have documented severe hyponatremia (as low as 101-109 mmol/L) with lisinopril that resolved upon discontinuation 1, 2, 3.

Management Algorithm

Current sodium 134 mmol/L:

1. Continue lisinopril 20 mg daily (your current reduced dose)
2. Recheck sodium in 1-2 weeks to confirm continued improvement
3. Target sodium ≥135 mmol/L before considering any dose increase

If sodium reaches ≥135 mmol/L:

• Maintain lisinopril 20 mg if blood pressure adequately controlled
• If BP control inadequate, consider adding a different class antihypertensive rather than increasing lisinopril

If sodium remains 131-134 mmol/L despite dose reduction:

• Consider discontinuing lisinopril entirely
• Switch to alternative antihypertensive (ARB, calcium channel blocker)
• Still no indication for sodium tablets

Only consider sodium supplementation if:

• Sodium drops below 130 mmol/L despite stopping lisinopril entirely
• Evidence of true salt wasting emerges (high urine sodium with volume depletion)

Why Sodium Tablets Are Not Indicated

According to FDA labeling, the recommended starting dose for lisinopril in patients with hyponatremia (sodium <130 mEq/L) is 2.5 mg once daily 4. Your patient is already at 20 mg with sodium of 134 mmol/L—well above the threshold requiring special dosing. Adding sodium tablets would:

• Address a problem that's already resolving
• Risk overcorrection
• Potentially mask the need to further adjust or discontinue the offending agent

Important Caveat

The neurosurgical guidelines 5 recommend treating hyponatremia aggressively only when:

• Severe symptoms present (seizures, altered mental status)
• Sodium <120 mmol/L
• Acute onset (<48 hours)

Your patient has mild, chronic, asymptomatic hyponatremia that improved with simple dose adjustment. The treatment algorithm for SIADH shows sodium tablets (100 mEq PO TID) are reserved for cases not responding to hypertonic saline—not for mild, improving hyponatremia 5.